Related Experiment Video
Updated: Jan 13, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Cyanopeptide Mixtures Induce Variable Synergistic and Antagonistic Effects Across Diverse Human Cell Lines
Lauren N Hart1,2, Katherine L Lev1,2, Sierra Hefferan2,3
1Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan, USA.
None:
Cyanobacterial harmful algal blooms (cyanoHABs) threaten human, animal, and ecosystem health and safety through production of toxic secondary metabolites. Microcystis, a cosmopolitan bloom-forming cyanobacterial genus, is well-known for producing hepatotoxic microcystins (MCs), but it can produce many other bioactive cyanopeptides, such as anabaenopeptins (APs), that occur at high levels in blooms. The toxicological and ecological impacts of such co-occurring cyanopeptides in the natural environment remain understudied. Here we evaluated the effects of pure MCs and APs individually and in combination, as well as extracts of Microcystis cultures producing diverse suites of cyanopeptides, including strains with and without MCs and APs, on human lung (A549), kidney (HK2), and liver (Hep-3B) cell viability. Individual MC and AP congeners exhibited a gradient of toxic effects across cell lines; MC-LA caused the most toxic effects, MC-LR had comparable effects to AP-A and AP-B, and MC-RR caused the least toxicity. Combined exposure to MC-LA and AP-B produced dose-dependent synergistic effects across all three cell lines. Microcystis culture extracts significantly reduced cell viability in dose- and Microcystis strain-dependent patterns that could not be explained by microcystin or anabaenopeptin content alone, suggesting a role of other metabolites and their interactions within the mixtures. These findings demonstrate that mixtures of environmentally relevant cyanopeptides can have greater toxic threats than individual compounds and underscore the importance of considering metabolites beyond MCs and their potential interactions in public health, future risk assessments, and management strategies for cyanoHAB-impacted waters.
More Related Videos
07:51High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...